Castleark Management’s St Jude Medical STJ Stock Holding History

Castleark Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-189,145	Closed	-$10.4M	–	420
2016 Q1	$10.4M	Sell	189,145 -198,960	-51%	-$10.8M	0.32%	79
2015 Q4	$24M	Sell	388,105 -311,100	-44%	-$19.6M	0.72%	35
2015 Q3	$44.1M	Sell	699,205 -56,435	-7%	-$4.03M	1.42%	17
2015 Q2	$55.2M	Buy	755,640 +107,411	+17%	+$7.76M	1.48%	8
2015 Q1	$42.4M	Sell	648,229 -173,081	-21%	-$11.5M	1.02%	23
2014 Q4	$53.4M	Buy	+821,310	New	+$52.9M	1.38%	19
2014 Q3	–	Sell	-857,730	Closed	-$59.4M	–	363
2014 Q2	$59.4M	Buy	+857,730	New	+$55.6M	1.64%	18
2013 Q4	–	Sell	-1,069,608	Closed	-$64.3M	–	431
2013 Q3	$64.3M	Buy	+1,069,608	New	+$55.1M	1.81%	10

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Castleark Management's STJ Position: Q2 2016 in Review

Castleark Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 189,145 shares — an estimated $10.4M sold.

Castleark Management first reported a position in STJ in Q3 2013 and held it in 8 quarters. The position peaked at $64.3M in Q3 2013. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

Castleark Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
Castleark Management sold 189,145 St Jude Medical shares in Q2 2016, an estimated $10.4M.
Castleark Management first reported a position in St Jude Medical in Q3 2013 and held it in 8 quarters.
Castleark Management's St Jude Medical position peaked at $64.3M in Q3 2013.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Castleark Management's 13F filing for Q2 2016, filed 10 Aug 2016.